BlackRock’s Orgenesis Inc. Common Stock ORGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,961
| Closed | -$26.6K | – | 5506 |
|
|
2024
Q3 | $26.6K | Sell |
5,961
-2,028
| -25% | -$13.5K | ﹤0.01% | 4905 |
|
|
2024
Q2 | $47.9K | Sell |
7,989
-4,534
| -36% | -$23.8K | ﹤0.01% | 4871 |
|
|
2024
Q1 | $103K | Sell |
12,523
-253
| -2% | -$1.35K | ﹤0.01% | 4720 |
|
|
2023
Q4 | $64K | Buy |
12,776
+998
| +8% | +$6.4K | ﹤0.01% | 4920 |
|
|
2023
Q3 | $73K | Sell |
11,778
-1,479
| -11% | -$13.2K | ﹤0.01% | 4923 |
|
|
2023
Q2 | $184K | Buy |
13,257
+1,054
| +9% | +$12.5K | ﹤0.01% | 4757 |
|
|
2023
Q1 | $144K | Buy |
12,203
+147
| +1% | +$2.76K | ﹤0.01% | 4876 |
|
|
2022
Q4 | $235K | Buy |
12,056
+11
| +0.1% | +$187 | ﹤0.01% | 4806 |
|
|
2022
Q3 | $171K | Sell |
12,045
-163
| -1% | -$3.06K | ﹤0.01% | 5015 |
|
|
2022
Q2 | $295K | Sell |
12,208
-564
| -4% | -$15.7K | ﹤0.01% | 4929 |
|
|
2022
Q1 | $444K | Sell |
12,772
-259
| -2% | -$7.87K | ﹤0.01% | 4903 |
|
|
2021
Q4 | $376K | Buy |
13,031
+314
| +2% | +$12.3K | ﹤0.01% | 4958 |
|
|
2021
Q3 | $631K | Sell |
12,717
-89
| -0.7% | -$4.47K | ﹤0.01% | 4695 |
|
|
2021
Q2 | $650K | Sell |
12,806
-90,702
| -88% | -$4.57M | ﹤0.01% | 4625 |
|
|
2021
Q1 | $5.93M | Buy |
103,508
+5,869
| +6% | +$382K | ﹤0.01% | 3861 |
|
|
2020
Q4 | $4.39M | Buy |
97,639
+7,814
| +9% | +$376K | ﹤0.01% | 3767 |
|
|
2020
Q3 | $4.53M | Buy |
89,825
+215
| +0.2% | +$11.7K | ﹤0.01% | 3618 |
|
|
2020
Q2 | $5.45M | Buy |
89,610
+82,885
| +1,232% | +$5.02M | ﹤0.01% | 3488 |
|
|
2020
Q1 | $255K | Sell |
6,725
-189
| -3% | -$8.26K | ﹤0.01% | 4189 |
|
|
2019
Q4 | $322K | Buy |
6,914
+931
| +16% | +$31K | ﹤0.01% | 4241 |
|
|
2019
Q3 | $267K | Sell |
5,983
-189
| -3% | -$8.44K | ﹤0.01% | 4286 |
|
|
2019
Q2 | $274K | Buy |
6,172
+3,468
| +128% | +$156K | ﹤0.01% | 4308 |
|
|
2019
Q1 | $144K | Sell |
2,704
-185
| -6% | -$9.23K | ﹤0.01% | 4308 |
|
|
2018
Q4 | $135K | Buy |
2,889
+891
| +45% | +$51.2K | ﹤0.01% | 4300 |
|
|
2018
Q3 | $111K | Buy |
1,998
+81
| +4% | +$5.48K | ﹤0.01% | 4439 |
|
|
2018
Q2 | $166K | Buy |
+1,917
| New | +$178K | ﹤0.01% | 4358 |
|
BlackRock's ORGS Position: Q4 2024 in Review
BlackRock sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2024, closing a stake of 5,961 shares — an estimated $26.6K sold.
BlackRock first reported a position in ORGS in Q2 2018 and held it in 26 quarters. The position peaked at $5.93M in Q1 2021. 0 funds tracked by Wall St. Rank hold ORGS as of Q4 2024.
- BlackRock reported no remaining Orgenesis Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- BlackRock sold 5,961 Orgenesis Inc. Common Stock shares in Q4 2024, an estimated $26.6K.
- BlackRock first reported a position in Orgenesis Inc. Common Stock in Q2 2018 and held it in 26 quarters.
- BlackRock's Orgenesis Inc. Common Stock position peaked at $5.93M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2024.
Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.